Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Seroprevalence of Zika virus in selected regions in Kenya.

Kisuya B, Masika MM, Bahizire E, Oyugi JO.

Trans R Soc Trop Med Hyg. 2019 Oct 22. pii: trz077. doi: 10.1093/trstmh/trz077. [Epub ahead of print]

PMID:
31639184
2.

Medroxyprogesterone acetate alters the vaginal microbiota and microenvironment in women and increases susceptibility to HIV-1 in humanized mice.

Wessels JM, Lajoie J, Cooper MIJH, Omollo K, Felker AM, Vitali D, Dupont HA, Nguyen PV, Mueller K, Vahedi F, Kimani J, Oyugi J, Cheruiyot J, Mungai JN, Deshiere A, Tremblay MJ, Mazzulli T, Stearns JC, Ashkar AA, Fowke KR, Surette MG, Kaushic C.

Dis Model Mech. 2019 Oct 23;12(10). pii: dmm039669. doi: 10.1242/dmm.039669.

3.

Household characteristics as predictors of access to paediatric malaria treatment in Homa-Bay County, Kenya.

Kodhiambo MO, Amugune BK, Oyugi JO.

BMC Res Notes. 2019 Aug 7;12(1):490. doi: 10.1186/s13104-019-4514-7.

4.

HIV-Related Deaths in Nairobi, Kenya: Results From a HIV Mortuary Surveillance Study, 2015.

Nyagah LM, Young PW, Kim AA, Wamicwe J, Kimani M, Waruiru W, Rogena E, Oduor J, Walong E, Waruru A, Oyugi J, Downer M, De Cock KM, Sirengo M.

J Acquir Immune Defic Syndr. 2019 May 1;81(1):18-23. doi: 10.1097/QAI.0000000000001975.

PMID:
30964803
5.

Noncommunicable disease burden among HIV patients in care: a national retrospective longitudinal analysis of HIV-treatment outcomes in Kenya, 2003-2013.

Achwoka D, Waruru A, Chen TH, Masamaro K, Ngugi E, Kimani M, Mukui I, Oyugi JO, Mutave R, Achia T, Katana A, Ng'ang'a L, De Cock KM.

BMC Public Health. 2019 Apr 3;19(1):372. doi: 10.1186/s12889-019-6716-2.

6.

Increased Cervical CD4+CCR5+ T Cells Among Kenyan Sex Working Women Using Depot Medroxyprogesterone Acetate.

Lajoie J, Tjernlund A, Omollo K, Edfeldt G, Röhl M, Boily-Larouche G, Cheruiyot J, Kimani M, Kimani J, Oyugi J, Broliden K, Fowke KR.

AIDS Res Hum Retroviruses. 2019 Mar;35(3):236-246. doi: 10.1089/AID.2018.0188. Epub 2019 Jan 24.

7.

Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.

Joag V, Obila O, Gajer P, Scott MC, Dizzell S, Humphrys M, Shahabi K, Huibner S, Shannon B, Tharao W, Mureithi M, Oyugi J, Kimani J, Kaushic C, Ravel J, Anzala O, Kaul R.

Clin Infect Dis. 2019 May 2;68(10):1675-1683. doi: 10.1093/cid/ciy762.

8.

Characterization of the Genital Mucosa Immune Profile to Distinguish Phases of the Menstrual Cycle: Implications for HIV Susceptibility.

Boily-Larouche G, Lajoie J, Dufault B, Omollo K, Cheruiyot J, Njoki J, Kowatsch M, Kimani M, Kimani J, Oyugi J, Fowke KR.

J Infect Dis. 2019 Feb 23;219(6):856-866. doi: 10.1093/infdis/jiy585.

9.

Utilization of Kenya's free maternal health services among women living in Kibera slums: a cross-sectional study.

Owiti A, Oyugi J, Essink D.

Pan Afr Med J. 2018 May 30;30:86. doi: 10.11604/pamj.2018.30.86.15151. eCollection 2018.

10.

Using safe, affordable and accessible non-steroidal anti-inflammatory drugs to reduce the number of HIV target cells in the blood and at the female genital tract.

Lajoie J, Birse K, Mwangi L, Chen Y, Cheruiyot J, Akolo M, Mungai J, Boily-Larouche G, Romas L, Mutch S, Kimani M, Oyugi J, Ho EA, Burgener A, Kimani J, Fowke KR.

J Int AIDS Soc. 2018 Jul;21(7):e25150. doi: 10.1002/jia2.25150.

11.

The incidence of first-line antiretroviral treatment changes and related factors among HIV-infected sex workers in Nairobi, Kenya.

Ndakala FN, Oyugi JO, Oluka MN, Kimani J, Norbert Behrens GM.

Pan Afr Med J. 2017 Sep 5;28:7. doi: 10.11604/pamj.2017.28.7.10885. eCollection 2017.

12.

Association of high-risk sexual behaviour with diversity of the vaginal microbiota and abundance of Lactobacillus.

Wessels JM, Lajoie J, Vitali D, Omollo K, Kimani J, Oyugi J, Cheruiyot J, Kimani M, Mungai JN, Akolo M, Stearns JC, Surette MG, Fowke KR, Kaushic C.

PLoS One. 2017 Nov 2;12(11):e0187612. doi: 10.1371/journal.pone.0187612. eCollection 2017.

13.

Stool Xpert MTB/RIF and urine lipoarabinomannan for the diagnosis of tuberculosis in hospitalized HIV-infected children.

LaCourse SM, Pavlinac PB, Cranmer LM, Njuguna IN, Mugo C, Gatimu J, Stern J, Walson JL, Maleche-Obimbo E, Oyugi J, Wamalwa D, John-Stewart G.

AIDS. 2018 Jan 2;32(1):69-78. doi: 10.1097/QAD.0000000000001662.

14.

CD161 identifies polyfunctional Th1/Th17 cells in the genital mucosa that are depleted in HIV-infected female sex workers from Nairobi, Kenya.

Boily-Larouche G, Omollo K, Cheruiyot J, Njoki J, Kimani M, Kimani J, Oyugi J, Lajoie J, Fowke KR.

Sci Rep. 2017 Sep 11;7(1):11123. doi: 10.1038/s41598-017-11706-y.

15.

Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis.

Kamakia R, Kiazyk S, Waruk J, Meyers A, Ochanda J, Ball TB, Oyugi J.

Int J Tuberc Lung Dis. 2017 Mar 1;21(3):278-285. doi: 10.5588/ijtld.16.0176.

PMID:
28225338
16.

Prevalent neuropathy in a cohort of HIV-infected Kenyan sex workers using antiretroviral drugs.

Ndakala FN, Oyugi JO, Oluka MN, Kimani J, Jablonka A, Behrens GM.

Pan Afr Med J. 2016 Sep 20;25:14. doi: 10.11604/pamj.2016.25.14.9699. eCollection 2016.

17.

Increasing insecticide resistance in Anopheles funestus and Anopheles arabiensis in Malawi, 2011-2015.

Mzilahowa T, Chiumia M, Mbewe RB, Uzalili VT, Luka-Banda M, Kutengule A, Mathanga DP, Ali D, Chiphwanya J, Zoya J, Mulenga S, Dodoli W, Bergeson-Lockwood J, Troell P, Oyugi J, Lindblade K, Gimnig JE.

Malar J. 2016 Nov 22;15(1):563.

18.

Improving Adherence to Post-Cervical Biopsy Sexual Abstinence in Kenyan Female Sex Workers.

Lajoie J, Boily-Larouche G, Doering K, Cheruiyot J, Oyugi J, Broliden K, Kimani J, Fowke KR.

Am J Reprod Immunol. 2016 Jul;76(1):82-93. doi: 10.1111/aji.12520. Epub 2016 May 24.

19.

Building capacity in implementation science research training at the University of Nairobi.

Osanjo GO, Oyugi JO, Kibwage IO, Mwanda WO, Ngugi EN, Otieno FC, Ndege W, Child M, Farquhar C, Penner J, Talib Z, Kiarie JN.

Implement Sci. 2016 Mar 8;11:30. doi: 10.1186/s13012-016-0395-5.

20.

Hepatitis B infection is highly prevalent among patients presenting with jaundice in Kenya.

Ochwoto M, Kimotho JH, Oyugi J, Okoth F, Kioko H, Mining S, Budambula NL, Giles E, Andonov A, Songok E, Osiowy C.

BMC Infect Dis. 2016 Mar 1;16:101. doi: 10.1186/s12879-016-1409-2.

21.

The Impact of Sex Work Interruption on Blood-Derived T Cells in Sex Workers from Nairobi, Kenya.

Omollo K, Boily-Larouche G, Lajoie J, Kimani M, Cheruiyot J, Kimani J, Oyugi J, Fowke KR.

AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):1072-1078. Epub 2016 Mar 16.

22.

Mucosal Blood Group Antigen Expression Profiles and HIV Infections: A Study among Female Sex Workers in Kenya.

Chanzu NM, Mwanda W, Oyugi J, Anzala O.

PLoS One. 2015 Jul 17;10(7):e0133049. doi: 10.1371/journal.pone.0133049. eCollection 2015.

23.

Effects of HIV-1 infection on malaria parasitemia in milo sub-location, western Kenya.

Rutto EK, Nyagol J, Oyugi J, Ndege S, Onyango N, Obala A, Simiyu CJ, Boor G, Cheriro WC, Otsyula B, Estambale B.

BMC Res Notes. 2015 Jul 15;8:303. doi: 10.1186/s13104-015-1270-1.

24.

Cytokine and chemokine expression profiles in response to Mycobacterium tuberculosis stimulation are altered in HIV-infected compared to HIV-uninfected subjects with active tuberculosis.

Waruk JL, Machuki Z, Mesa C, Juno JA, Anzala O, Sharma M, Ball TB, Oyugi J, Kiazyk S.

Tuberculosis (Edinb). 2015 Sep;95(5):555-61. doi: 10.1016/j.tube.2015.05.001. Epub 2015 May 22.

PMID:
26073895
25.

Detection and Genome Analysis of a Lineage III Peste Des Petits Ruminants Virus in Kenya in 2011.

Dundon WG, Kihu SM, Gitao GC, Bebora LC, John NM, Oyugi JO, Loitsch A, Diallo A.

Transbound Emerg Dis. 2017 Apr;64(2):644-650. doi: 10.1111/tbed.12374. Epub 2015 May 11.

PMID:
25962318
26.

Identification of preferential CD4+ T-cell targets for HIV infection in the cervix.

Joag VR, McKinnon LR, Liu J, Kidane ST, Yudin MH, Nyanga B, Kimwaki S, Besel KE, Obila JO, Huibner S, Oyugi JO, Arthos J, Anzala O, Kimani J, Ostrowski MA; Toronto HIV Research Group, Kaul R.

Mucosal Immunol. 2016 Jan;9(1):1-12. doi: 10.1038/mi.2015.28. Epub 2015 Apr 15.

PMID:
25872482
27.

Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment.

Juno JA, Stalker AT, Waruk JL, Oyugi J, Kimani M, Plummer FA, Kimani J, Fowke KR.

Retrovirology. 2015 Feb 13;12:17. doi: 10.1186/s12977-015-0142-z.

28.

First Complete Genome Sequence of a Lineage III Peste des Petits Ruminants Virus.

Dundon WG, Kihu SM, Settypalli TB, Gitao GC, Bebora LC, John NM, Oyugi JO, Silber R, Loitsch A, Diallo A.

Genome Announc. 2014 Oct 23;2(5). pii: e01054-14. doi: 10.1128/genomeA.01054-14.

29.

Detection of peste des petits ruminants virus in formalin-fixed tissues.

Kihu SM, Gitao GC, Bebora LC, Njenga MJ, Wairire GG, Maingi N, Wahome RG, Oyugi JO, Lutomia E.

Trop Anim Health Prod. 2015 Jan;47(1):247-9. doi: 10.1007/s11250-014-0707-1. Epub 2014 Oct 19.

PMID:
25326718
30.

Enrichment of LAG-3, but not PD-1, on double negative T cells at the female genital tract.

Juno JA, Lajoie J, Stalker AT, Oyugi J, Kimani M, Kimani J, Plummer FA, Fowke KR.

Am J Reprod Immunol. 2014 Dec;72(6):534-40. doi: 10.1111/aji.12308. Epub 2014 Aug 25.

PMID:
25154740
31.

Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda.

Lee GQ, Bangsberg DR, Muzoora C, Boum Y, Oyugi JH, Emenyonu N, Bennett J, Hunt PW, Knapp D, Brumme CJ, Harrigan PR, Martin JN.

AIDS Res Hum Retroviruses. 2014 Sep;30(9):896-906. doi: 10.1089/AID.2014.0043. Epub 2014 Jul 29.

32.

Quality of malaria case management in Malawi: results from a nationally representative health facility survey.

Steinhardt LC, Chinkhumba J, Wolkon A, Luka M, Luhanga M, Sande J, Oyugi J, Ali D, Mathanga D, Skarbinski J.

PLoS One. 2014 Feb 20;9(2):e89050. doi: 10.1371/journal.pone.0089050. eCollection 2014.

33.

Patient-, health worker-, and health facility-level determinants of correct malaria case management at publicly funded health facilities in Malawi: results from a nationally representative health facility survey.

Steinhardt LC, Chinkhumba J, Wolkon A, Luka M, Luhanga M, Sande J, Oyugi J, Ali D, Mathanga D, Skarbinski J.

Malar J. 2014 Feb 20;13:64. doi: 10.1186/1475-2875-13-64.

34.

Antagonistic effect of alkaloids and saponins on bioactivity in the quinine tree (Rauvolfia caffra sond.): further evidence to support biotechnology in traditional medicinal plants.

Milugo TK, Omosa LK, Ochanda JO, Owuor BO, Wamunyokoli FA, Oyugi JO, Ochieng JW.

BMC Complement Altern Med. 2013 Oct 26;13:285. doi: 10.1186/1472-6882-13-285.

35.

Free HIV antiretroviral therapy enhances adherence among individuals on stable treatment: implications for potential shortfalls in free antiretroviral therapy.

Byakika-Tusiime J, Polley EC, Oyugi JH, Bangsberg DR.

PLoS One. 2013 Sep 5;8(9):e70375. doi: 10.1371/journal.pone.0070375. eCollection 2013.

36.

Characterization of Vibrio cholerae bacteriophages isolated from the environmental waters of the Lake Victoria region of Kenya.

Maina AN, Mwaura FB, Oyugi J, Goulding D, Toribio AL, Kariuki S.

Curr Microbiol. 2014 Jan;68(1):64-70. doi: 10.1007/s00284-013-0447-x. Epub 2013 Aug 28.

37.

C868T single nucleotide polymorphism and HIV type 1 disease progression among postpartum women in Kenya.

Choi RY, Fowke KR, Juno J, Lohman-Payne B, Oyugi JO, Brown ER, Bosire R, John-Stewart G, Farquhar C.

AIDS Res Hum Retroviruses. 2012 Jun;28(6):566-70. doi: 10.1089/AID.2011.0095. Epub 2011 Sep 27.

38.

Prevention of human immunodeficiency virus breastmilk transmission with copper oxide: proof-of-concept study.

Borkow G, Covington CY, Gautam B, Anzala O, Oyugi J, Juma M, Abdullah MS.

Breastfeed Med. 2011 Aug;6(4):165-70. doi: 10.1089/bfm.2010.0090.

PMID:
21770731
39.
40.

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.

DART Trial Team, Mugyenyi P, Walker AS, Hakim J, Munderi P, Gibb DM, Kityo C, Reid A, Grosskurth H, Darbyshire JH, Ssali F, Bray D, Katabira E, Babiker AG, Gilks CF, Grosskurth H, Munderi P, Kabuye G, Nsibambi D, Kasirye R, Zalwango E, Nakazibwe M, Kikaire B, Nassuna G, Massa R, Fadhiru K, Namyalo M, Zalwango A, Generous L, Khauka P, Rutikarayo N, Nakahima W, Mugisha A, Todd J, Levin J, Muyingo S, Ruberantwari A, Kaleebu P, Yirrell D, Ndembi N, Lyagoba F, Hughes P, Aber M, Lara AM, Foster S, Amurwon J, Wakholi BN, Whitworth J, Wangati K, Amuron B, Kajungu D, Nakiyingi J, Omony W, Fadhiru K, Nsibambi D, Khauka P, Mugyenyi P, Kityo C, Ssali F, Tumukunde D, Otim T, Kabanda J, Musana H, Akao J, Kyomugisha H, Byamukama A, Sabiiti J, Komugyena J, Wavamunno P, Mukiibi S, Drasiku A, Byaruhanga R, Labeja O, Katundu P, Tugume S, Awio P, Namazzi A, Bakeinyaga GT, Katabira H, Abaine D, Tukamushaba J, Anywar W, Ojiambo W, Angweng E, Murungi S, Haguma W, Atwiine S, Kigozi J, Namale L, Mukose A, Mulindwa G, Atwiine D, Muhwezi A, Nimwesiga E, Barungi G, Takubwa J, Murungi S, Mwebesa D, Kagina G, Mulindwa M, Ahimbisibwe F, Mwesigwa P, Akuma S, Zawedde C, Nyiraguhirwa D, Tumusiime C, Bagaya L, Namara W, Kigozi J, Karungi J, Kankunda R, Enzama R, Latif A, Hakim J, Robertson V, Reid A, Chidziva E, Bulaya-Tembo R, Musoro G, Taziwa F, Chimbetete C, Chakonza L, Mawora A, Muvirimi C, Tinago G, Svovanapasis P, Simango M, Chirema O, Machingura J, Mutsai S, Phiri M, Bafana T, Chirara M, Muchabaiwa L, Muzambi M, Mutowo J, Chivhunga T, Chigwedere E, Pascoe M, Warambwa C, Zengeza E, Mapinge F, Makota S, Jamu A, Ngorima N, Chirairo H, Chitsungo S, Chimanzi J, Maweni C, Warara R, Matongo M, Mudzingwa S, Jangano M, Moyo K, Vere L, Mdege N, Machingura I, Katabira E, Ronald A, Kambungu A, Lutwama F, Mambule I, Nanfuka A, Walusimbi J, Nabankema E, Nalumenya R, Namuli T, Kulume R, Namata I, Nyachwo L, Florence A, Kusiima A, Lubwama E, Nairuba R, Oketta F, Buluma E, Waita R, Ojiambo H, Sadik F, Wanyama J, Nabongo P, Oyugi J, Sematala F, Muganzi A, Twijukye C, Byakwaga H, Ochai R, Muhweezi D, Coutinho A, Etukoit B, Gilks C, Boocock K, Puddephatt C, Grundy C, Bohannon J, Winogron D, Gibb DM, Burke A, Bray D, Babiker A, Walker AS, Wilkes H, Rauchenberger M, Sheehan S, Spencer-Drake C, Taylor K, Spyer M, Ferrier A, Naidoo B, Dunn D, Goodall R, Darbyshire JH, Peto L, Nanfuka R, Mufuka-Kapuya C, Kaleebu P, Pillay D, Robertson V, Yirrell D, Tugume S, Chirara M, Katundu P, Ndembi N, Lyagoba F, Dunn D, Goodall R, McCormick A, Lara AM, Foster S, Amurwon J, Wakholi BN, Kigozi J, Muchabaiwa L, Muzambi M, Weller I, Babiker A, Bahendeka S, Bassett M, Wapakhabulo AC, Darbyshire JH, Gazzard B, Gilks C, Grosskurth H, Hakim J, Latif A, Mapuchere C, Mugurungi O, Mugyenyi P, Burke C, Jones S, Newland C, Pearce G, Rahim S, Rooney J, Smith M, Snowden W, Steens JM, Breckenridge A, McLaren A, Hill C, Matenga J, Pozniak A, Serwadda D, Peto T, Palfreeman A, Borok M, Katabira E.

Lancet. 2010 Jan 9;375(9709):123-31. doi: 10.1016/S0140-6736(09)62067-5. Epub 2009 Dec 8.

41.

Training needs assessment for clinicians at antiretroviral therapy clinics: evidence from a national survey in Uganda.

Lutalo IM, Schneider G, Weaver MR, Oyugi JH, Sebuyira LM, Kaye R, Lule F, Namagala E, Scheld WM, McAdam KP, Sande MA.

Hum Resour Health. 2009 Aug 23;7:76. doi: 10.1186/1478-4491-7-76.

42.

A common CD4 gene variant is associated with an increased risk of HIV-1 infection in Kenyan female commercial sex workers.

Oyugi JO, Vouriot FC, Alimonti J, Wayne S, Luo M, Land AM, Ao Z, Yao X, Sekaly RP, Elliott LJ, Simonsen JN, Ball TB, Jaoko W, Kimani J, Plummer FA, Fowke KR.

J Infect Dis. 2009 May 1;199(9):1327-34. doi: 10.1086/597616.

PMID:
19301975
43.

Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time.

Byakika-Tusiime J, Crane J, Oyugi JH, Ragland K, Kawuma A, Musoke P, Bangsberg DR.

AIDS Behav. 2009 Jun;13 Suppl 1:82-91. doi: 10.1007/s10461-009-9546-x. Epub 2009 Mar 20.

PMID:
19301113
44.

Steady state bioequivalence of generic and innovator formulations of stavudine, lamivudine, and nevirapine in HIV-infected Ugandan adults.

Byakika-Tusiime J, Chinn LW, Oyugi JH, Obua C, Bangsberg DR, Kroetz DL.

PLoS One. 2008;3(12):e3981. doi: 10.1371/journal.pone.0003981. Epub 2008 Dec 19.

45.

Hepatotoxicity during nevirapine-based fixed-dose combination antiretroviral therapy in kampala, Uganda.

Hahn JA, Maier M, Byakika-Tusiime J, Oyugi JH, Bangsberg DR.

J Int Assoc Physicians AIDS Care (Chic). 2007 Jun;6(2):83-6.

PMID:
17537997
46.

Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda.

Oyugi JH, Byakika-Tusiime J, Ragland K, Laeyendecker O, Mugerwa R, Kityo C, Mugyenyi P, Quinn TC, Bangsberg DR.

AIDS. 2007 May 11;21(8):965-71.

PMID:
17457090
47.

Global warming and the emergence of ancient pathogens in Canada's arctic regions.

Oyugi JO, Qiu H, Safronetz D.

Med Hypotheses. 2007;68(3):709. Epub 2006 Oct 24. No abstract available.

PMID:
17064851
48.
49.

Adherence to HIV antiretroviral therapy in HIV+ Ugandan patients purchasing therapy.

Byakika-Tusiime J, Oyugi JH, Tumwikirize WA, Katabira ET, Mugyenyi PN, Bangsberg DR.

Int J STD AIDS. 2005 Jan;16(1):38-41.

PMID:
15705271
50.

Etiology of pruritic papular eruption with HIV infection in Uganda.

Resneck JS Jr, Van Beek M, Furmanski L, Oyugi J, LeBoit PE, Katabira E, Kambugu F, Maurer T, Berger T, Pletcher MJ, Machtinger EL.

JAMA. 2004 Dec 1;292(21):2614-21.

PMID:
15572719

Supplemental Content

Support Center